Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Feb;35(2):382–383. doi: 10.1128/aac.35.2.382

Oral acyclovir therapy of recurrent herpes simplex virus type 2 infection of the hand.

M J Gill 1, H E Bryant 1
PMCID: PMC245012  PMID: 1850971

Abstract

Acyclovir was evaluated as treatment of recurrent herpes simplex virus type 2 infection of the hand in a double-blind, placebo-controlled crossover study. In nine fully evaluable patients, oral acyclovir (2 g/day in three doses for 10 days) initiated during the earliest phase of a recurrence reduced the mean durations (+/- standard deviation) of clinical symptoms from 10.1 (+/- 3.6) to 3.7 (+/- 3.0) days (P = 0.008), signs from 11.1 (+/- 3.7) to 6.2 (+/- 3.3) days (P = 0.024), and viral positivity from 5.3 (+/- 3.8) to 0.6 (+/- 1.1) days (P = 0.011).

Full text

PDF
382

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fowler J. R. Viral infections. Hand Clin. 1989 Nov;5(4):613–627. [PubMed] [Google Scholar]
  2. Gill M. J., Arlette J., Buchan K. A. Herpes simplex virus infection of the hand. J Am Acad Dermatol. 1990 Jan;22(1):111–116. doi: 10.1016/0190-9622(90)70018-d. [DOI] [PubMed] [Google Scholar]
  3. Gill M. J., Arlette J., Buchan K. Herpes simplex virus infection of the hand. A profile of 79 cases. Am J Med. 1988 Jan;84(1):89–93. doi: 10.1016/0002-9343(88)90013-7. [DOI] [PubMed] [Google Scholar]
  4. Gill M. J., Arlette J., Buchan K., Tyrrell D. L. Therapy for recurrent herpetic whitlow. Ann Intern Med. 1986 Oct;105(4):631–631. doi: 10.7326/0003-4819-105-4-631_1. [DOI] [PubMed] [Google Scholar]
  5. Juel-Jensen B. E. Herpetic whitlows: results of treatment with idoxuridine. J Am Coll Health Assoc. 1970 Feb;18(3):227–230. [PubMed] [Google Scholar]
  6. Laskin O. L. Acyclovir and suppression of frequently recurring herpetic whitlow. Ann Intern Med. 1985 Apr;102(4):494–495. doi: 10.7326/0003-4819-102-4-494. [DOI] [PubMed] [Google Scholar]
  7. Mertz G. J., Critchlow C. W., Benedetti J., Reichman R. C., Dolin R., Connor J., Redfield D. C., Savoia M. C., Richman D. D., Tyrrell D. L. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA. 1984 Sep 7;252(9):1147–1151. [PubMed] [Google Scholar]
  8. Polayes I. M., Arons M. S. The treatment of herpetic whitlow--a new surgical concept. Plast Reconstr Surg. 1980 Jun;65(6):811–817. doi: 10.1097/00006534-198006000-00014. [DOI] [PubMed] [Google Scholar]
  9. Reichman R. C., Badger G. J., Mertz G. J., Corey L., Richman D. D., Connor J. D., Redfield D., Savoia M. C., Oxman M. N., Bryson Y. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA. 1984 Apr 27;251(16):2103–2107. [PubMed] [Google Scholar]
  10. Straus S. E., Takiff H. E., Seidlin M., Bachrach S., Lininger L., DiGiovanna J. J., Western K. A., Smith H. A., Lehrman S. N., Creagh-Kirk T. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984 Jun 14;310(24):1545–1550. doi: 10.1056/NEJM198406143102401. [DOI] [PubMed] [Google Scholar]
  11. Whitley R. J., Alford C. A., Hirsch M. S., Schooley R. T., Luby J. P., Aoki F. Y., Hanley D., Nahmias A. J., Soong S. J. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16;314(3):144–149. doi: 10.1056/NEJM198601163140303. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES